CompletedNCT01081080Updated Jan 11, 2013

Cardiac Magnetic Resonance in Children With Muscular Dystrophy

An observational study in Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Limb Girdle Muscular Dystrophy, sponsored by Cooperative International Neuromuscular Research Group. Completed at 2 sites in United States. Open to participants aged 8 Years to 18 Years. Per ClinicalTrials.gov, last updated 2013-01-11.

Sponsored by Cooperative International Neuromuscular Research Group · Observational

Study type: Observational
Model: Cohort
Time perspective: Prospective
Enrollment: 20
Ages: 8 Years to 18 Years
Sex: All

Study summary

This protocol will exploit novel state of the art cardiovascular magnetic resonance techniques to examine important changes in the heart in children with muscular dystrophy. The purpose of this study is to compare cardiac magnetic resonance (CMR) with the collected cardiac outcome data obtained in protocol: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy.

Conditions studied

Duchenne Muscular Dystrophy
Becker Muscular Dystrophy
Limb Girdle Muscular Dystrophy

Browse trials for

Keywords

cardiac
muscle
pediatric
dystrophy

In context

Muscular Dystrophies

548 studies on the registry are indexed under Muscular Dystrophies; 89 are open to participants now.

This study's planned enrollment of 20 is below the median of 69 across 179 observational studies indexed under Muscular Dystrophies.

Browse Muscular Dystrophies studies →

Lead sponsor

Cooperative International Neuromuscular Research Group is the lead sponsor of 17 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 8 Years to 18 Years
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

Participants will be recruited from the parallel protocol: PITT1109 Cardiac Outcome Measures in Children with Muscular Dystrophy

Inclusion criteria

Participant enrolled in the CINRG study: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy

Exclusion criteria

Exclusion Criteria:

Pregnant woman (when uncertain, participants will undergo urine testing) or lactating women
Decompensated congestive heart failure (unable to lie flat during CMR)
Impaired renal excretory function (calculated Glomerular Filtration Rate less than 30mL/min)
Contra-indications to Magnetic Resonance Imaging:
- Cardiac pacemaker or implantable defibrillator
- Cerebral aneurysm clip
- Neural stimulator
- Metallic ocular foreign body
- Harrington-rod
- Any implanted device (i.e. insulin pump, drug infusion device)
- Claustrophobia
- Metal shrapnel or bullet

Study design

Observational model: Cohort
Time perspective: Prospective
Enrollment: 20 participants (estimated)

Study locations

2 sites

Children's National Medical Center
Washington, District of Columbia 20010, United States
University of Pittsburgh
Pittsburgh, Pennsylvania 15213, United States

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Jan 11, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT01081080
Lead sponsor: Cooperative International Neuromuscular Research Group
Collaborators: National Institutes of Health (NIH)
First posted: Mar 5, 2010
Start date: Apr 2010
Primary completion: Oct 2011
Completion: Oct 2011
Last update: Jan 11, 2013

Study contacts

Paula R Clemens, MD

study chair · University of Pittsburgh

Oversight

Data monitoring committee: Yes

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Muscular Dystrophies→

Other studies from this sponsor

Cooperative International Neuromuscular Research Group

Start the discussion